about
Role of the p66Shc isoform in insulin-like growth factor I receptor signaling through MEK/Erk and regulation of actin cytoskeleton in rat myoblastsDifferences in gene expression and cytokine release profiles highlight the heterogeneity of distinct subsets of adipose tissue-derived stem cells in the subcutaneous and visceral adipose tissue in humansTNFα signals via p66(Shc) to induce E-Selectin, promote leukocyte transmigration and enhance permeability in human endothelial cells.Human adipose tissue precursor cells: a new factor linking regulation of fat mass to obesity and type 2 diabetes?The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis.Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway.Cross-Talk between PPARgamma and Insulin Signaling and Modulation of Insulin Sensitivity.The p66Shc protein controls redox signaling and oxidation-dependent DNA damage in human liver cells.Insulin signaling in human visceral and subcutaneous adipose tissue in vivo.Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane.Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling.Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells.Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study.Irisin increases the expression of anorexigenic and neurotrophic genes in mouse brainEfficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysisThe Role of Oxidative Stress in Cardiac Disease: From Physiological Response to Injury Factor
P50
Q28578240-1647FAF9-03FE-4E68-A816-59B016DD6F3AQ34634032-B5880814-2B78-47C3-A792-583AD9A0B42FQ35069855-696A9066-68A7-44A4-B95F-63EE70DFE801Q37603363-0B14FFC5-BF0F-4455-A660-93D1DA7E5559Q37701606-77FBEFCE-041A-4876-A5DD-BEB68901055EQ39101720-308566BC-2BAE-481F-85B0-978FC13E335EQ39209941-63721BB1-39BF-4699-928B-B55B9D9F0B83Q41017508-A5B28B8F-EF1D-4B83-ACA5-65F1FA4C49A8Q42492668-D68AEEDF-99EB-4439-B307-4716DF45E52FQ42832931-FAC9589F-AB22-4214-90EE-5FEED8BC32B9Q45163002-1E5B3D39-A337-4CD7-9B94-32AC868E3074Q46932219-D9629D96-C1B2-4F5B-B51A-C91BF613E233Q51252378-88B28DDF-6E00-4869-A5F0-DDFF3AE21C7EQ91337187-E5C985C8-EACB-4E55-BECD-4F51E6092B2DQ92095965-0B242C3C-71AF-42F2-879A-D69020DB73D5Q96172005-EE6EC6C0-DDA0-4E9B-A82A-64F5ED08D434
P50
description
researcher, ORCID id # 0000-0001-8860-5845
@en
wetenschapper
@nl
name
Luigi Laviola
@ast
Luigi Laviola
@en
Luigi Laviola
@es
Luigi Laviola
@nl
type
label
Luigi Laviola
@ast
Luigi Laviola
@en
Luigi Laviola
@es
Luigi Laviola
@nl
prefLabel
Luigi Laviola
@ast
Luigi Laviola
@en
Luigi Laviola
@es
Luigi Laviola
@nl
P106
P21
P31
P496
0000-0001-8860-5845